Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
JB Chemicals & Pharmaceuticals Limited logo

JB Chemicals & Pharmaceuticals Limited

JBCHEPHARM·Pharmaceuticals

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally.

183Announcements
08-07-2026Last filed
11Last 90 days

What JB files

  • Others72
  • Important35
  • Investor Meet23
  • Updates22
  • Dividend/Bonus9
  • Board Meeting8
Showing Updates announcements (22)Clear filter
08-07-2026 · 11:32 am

J.B. Chemicals & Pharmaceuticals' merger with Torrent Pharmaceuticals is now effective. J.B. Chemicals has amalgamated into Torrent Pharma and is dissolved, a key business development impacting both entities.

Read the full announcement→
PDF
07-07-2026 · 06:03 pm

J.B. Chemicals & Pharmaceuticals announced that the NCLT sanctioned its amalgamation scheme with Torrent Pharmaceuticals. The company has received the certified order, finalizing the merger process.

Read the full announcement→
PDF
06-07-2026 · 06:49 pm

J. B. Chemicals & Pharma's merger with Torrent Pharma received NCLT sanction. This key approval advances the amalgamation process, nearing its effective date.

Read the full announcement→
PDF
15-06-2026 · 05:55 pm

JB Chemicals & Pharma: Mr. Bhushan Sachdev, EVP – Supply Chain Management, has resigned due to personal reasons. This marks a senior management change in a critical operational role.

Read the full announcement→
PDF
11-05-2026 · 09:03 pm

JB Pharma's Q4 FY26 saw revenue at 904 Cr (-5% YoY) and net profit at 101 Cr (-30% YoY), impacted by post-acquisition integration. FY26 revenue rose 6% to 4,148 Cr. Management expects recovery from Q1, citing temporary impacts and improving margins from cost synergies.

Read the full announcement→
PDF